Cargando…
PA01.42. New alternative therapies in mild cognitive impairment
PURPOSE: Mild cognitive impairment (MCI) is a frequent clinical entity, considered today to be a prodromal stage of Alzheimer's dementia, but not having until now a standardized pharmacological treatment. The aim of this study is to follow the outcome of the patients diagnosed with MCI non trea...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800975/ |